{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:21:34Z","timestamp":1788351694110,"version":"build-2803163510"},"reference-count":69,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"unspecified","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Special Project of Natural Science Foundation of China","award":["82441031"],"award-info":[{"award-number":["82441031"]}]},{"name":"Sichuan Science and Technology Program","award":["2026NSFSC1558"],"award-info":[{"award-number":["2026NSFSC1558"]}]},{"name":"Key Project of the National Natural Science Foundation of China","award":["82430076"],"award-info":[{"award-number":["82430076"]}]},{"name":"Postdoctoral Foundation of Sichuan Provincial People\u2019s Hospital","award":["2022BH018"],"award-info":[{"award-number":["2022BH018"]}]},{"name":"Science and Technology Innovation Key R&D Program of Chongqing","award":["CSTB2024TIAD-STX0005"],"award-info":[{"award-number":["CSTB2024TIAD-STX0005"]}]},{"name":"Youth Fund of the National Natural Science Foundation of China","award":["82301987"],"award-info":[{"award-number":["82301987"]}]},{"name":"Youth Fund of the National Natural Science Foundation of China","award":["82301989"],"award-info":[{"award-number":["82301989"]}]},{"name":"Youth Fund of the National Natural Science Foundation of China","award":["82302628"],"award-info":[{"award-number":["82302628"]}]},{"name":"Youth Fund of the National Natural Science Foundation of China","award":["82402704"],"award-info":[{"award-number":["82402704"]}]},{"name":"Youth Fund of the National Natural Science Foundation of China","award":["82502806"],"award-info":[{"award-number":["82502806"]}]},{"name":"General Program of National Natural Science Foundation of China","award":["82572023"],"award-info":[{"award-number":["82572023"]}]},{"DOI":"10.13039\/501100014219","name":"National Science Fund for Distinguished Young Scholars","doi-asserted-by":"publisher","award":["82225029"],"award-info":[{"award-number":["82225029"]}],"id":[{"id":"10.13039\/501100014219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"Postdoctoral Foundation of China","doi-asserted-by":"crossref","award":["2024M750363"],"award-info":[{"award-number":["2024M750363"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Postdoctoral Foundation of Sichuan Province","award":["TB2023092"],"award-info":[{"award-number":["TB2023092"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,5,22]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immune checkpoint blockade therapy aims to restore T-cell function within the tumor microenvironment (TME), eliciting durable antitumor responses. However, clinical response rates to PD-1\/PD-L1 inhibitors remain limited, particularly in immunologically \u201ccold\u201d tumors such as pancreatic cancer, underscoring the need for alternative immunotherapeutic strategies. V-set and immunoglobulin domain-containing 4 (VSIG4) has been implicated in tumor progression, but its functional role in T-cell regulation and mechanisms of tumor immune evasion remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Syngeneic tumor models and human VSIG4 knock-in mice were employed to investigate the therapeutic effect of VSIG4 blockade. Mouse-specific and human-specific neutralizing antibodies against VSIG4 were administered across multiple tumor types, including pancreatic cancer. Tumor-infiltrating immune cells were analyzed by flow cytometry and functional assays. Mechanistic studies examined the interaction between VSIG4 and solute carrier family 3 member 2 (SLC3A2) and its impact on amino acid transport, ion flux, and T-cell activation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Therapeutic blockade of VSIG4 significantly suppressed tumor growth and prolonged survival in several cancer models, with particular efficacy in pancreatic cancer. VSIG4 expression correlated with tumor aggressiveness, and its blockade reactivated CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells within the TME, enhancing intratumoral infiltration and effector function. Mechanistically, VSIG4 directly bound to SLC3A2, a chaperone for amino acid transporters, thereby impairing glutamine uptake, disrupting sodium and calcium flux, and ultimately suppressing T-cell activation. VSIG4 blockade restored nutrient and ion availability to CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells, thereby reinvigorating antitumor immunity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings define a previously unrecognized metabolic\u2013ionic checkpoint axis by which VSIG4 restricts T-cell activation through SLC3A2. Blockade of VSIG4 reprograms the TME and enhances antitumor immunity, highlighting VSIG4 as a promising therapeutic target, particularly in metabolically repressive tumors such as pancreatic cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2025-013562","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:55:10Z","timestamp":1780919710000},"page":"e013562","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["VSIG4 suppresses antitumor T cell immunity via the SLC3A2-dependent metabolic\u2013ionic checkpoint"],"prefix":"10.1136","volume":"14","author":[{"given":"Guoling","family":"Huang","sequence":"first","affiliation":[{"name":"The Key Laboratory for Human Disease Gene Study of Sichuan Province and the Department of Laboratory Medicine, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"},{"name":"Research Unit for Blindness Prevention of the Chinese Academy of Medical Sciences, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China"},{"name":"School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruirui","family":"He","sequence":"additional","affiliation":[{"name":"The Key Laboratory for Human Disease Gene Study of Sichuan Province and the Department of Laboratory Medicine, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"},{"name":"Research Unit for Blindness Prevention of the Chinese Academy of Medical Sciences, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China"},{"name":"School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"},{"name":"Personalized Drug Research and Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People\u2019s Hospital, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"The Key Laboratory for Human Disease Gene Study of Sichuan Province and the Department of Laboratory Medicine, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"},{"name":"Research Unit for Blindness Prevention of the Chinese Academy of Medical Sciences, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China"},{"name":"School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heping","family":"Wang","sequence":"additional","affiliation":[{"name":"The Key Laboratory for Human Disease Gene Study of Sichuan Province and the Department of Laboratory Medicine, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"},{"name":"Research Unit for Blindness Prevention of the Chinese Academy of Medical Sciences, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China"},{"name":"School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Li","sequence":"additional","affiliation":[{"name":"The Key Laboratory for Human Disease Gene Study of Sichuan Province and the Department of Laboratory Medicine, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"},{"name":"Research Unit for Blindness Prevention of the Chinese Academy of Medical Sciences, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China"},{"name":"School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zeng","sequence":"additional","affiliation":[{"name":"The Key Laboratory for Human Disease Gene Study of Sichuan Province and the Department of Laboratory Medicine, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"},{"name":"Research Unit for Blindness Prevention of the Chinese Academy of Medical Sciences, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China"},{"name":"School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panyin","family":"Shu","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Pan","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yi","sequence":"additional","affiliation":[{"name":"The Key Laboratory for Human Disease Gene Study of Sichuan Province and the Department of Laboratory Medicine, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"},{"name":"Research Unit for Blindness Prevention of the Chinese Academy of Medical Sciences, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China"},{"name":"School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Feng","sequence":"additional","affiliation":[{"name":"The Key Laboratory for Human Disease Gene Study of Sichuan Province and the Department of Laboratory Medicine, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"},{"name":"Research Unit for Blindness Prevention of the Chinese Academy of Medical Sciences, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China"},{"name":"School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Cui","sequence":"additional","affiliation":[{"name":"The Key Laboratory for Human Disease Gene Study of Sichuan Province and the Department of Laboratory Medicine, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"},{"name":"Research Unit for Blindness Prevention of the Chinese Academy of Medical Sciences, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China"},{"name":"School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyun","family":"Du","sequence":"additional","affiliation":[{"name":"The Key Laboratory for Human Disease Gene Study of Sichuan Province and the Department of Laboratory Medicine, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"},{"name":"Research Unit for Blindness Prevention of the Chinese Academy of Medical Sciences, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China"},{"name":"School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"},{"name":"Personalized Drug Research and Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People\u2019s Hospital, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, Department of Biotherapy, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Pathology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[{"name":"The Key Laboratory for Human Disease Gene Study of Sichuan Province and the Department of Laboratory Medicine, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"},{"name":"School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3186-3066","authenticated-orcid":false,"given":"Chenhui","family":"Wang","sequence":"additional","affiliation":[{"name":"The Key Laboratory for Human Disease Gene Study of Sichuan Province and the Department of Laboratory Medicine, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"},{"name":"Research Unit for Blindness Prevention of the Chinese Academy of Medical Sciences, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China"},{"name":"School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"},{"name":"Personalized Drug Research and Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People\u2019s Hospital, Chengdu, China"},{"name":"Chuan-Yu Joint key Laboratory for Pathological and Laboratory Medicine, Jinfeng Laboratory, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"2026090205001845000_14.6.e013562.1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar4060"},{"key":"2026090205001845000_14.6.e013562.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.03.006"},{"key":"2026090205001845000_14.6.e013562.3","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-22-0876"},{"key":"2026090205001845000_14.6.e013562.4","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-019-01548-1"},{"key":"2026090205001845000_14.6.e013562.5","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy551"},{"key":"2026090205001845000_14.6.e013562.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412082"},{"key":"2026090205001845000_14.6.e013562.7","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010529","article-title":"PD-1IR2 promotes tumor evasion via deregulating CD8+ T cell function","volume":"13","author":"Zang","year":"2025","journal-title":"J Immunother Cancer"},{"key":"2026090205001845000_14.6.e013562.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.016"},{"key":"2026090205001845000_14.6.e013562.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2020.09.006"},{"key":"2026090205001845000_14.6.e013562.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.06.010"},{"key":"2026090205001845000_14.6.e013562.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0273-y"},{"key":"2026090205001845000_14.6.e013562.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.04.007"},{"key":"2026090205001845000_14.6.e013562.13","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120236"},{"key":"2026090205001845000_14.6.e013562.14","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1158\/0008-5472.CAN-24-3180","article-title":"SLC3A2-Mediated Lysine Uptake by Cancer Cells Restricts T-cell Activity in Hepatocellular Carcinoma","volume":"85","author":"Chang","year":"2025","journal-title":"Cancer Res"},{"key":"2026090205001845000_14.6.e013562.15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/mdb2.70001","article-title":"Human Organoids and Their Application in Tumor Models, Disease Modeling, and Tissue Engineering","volume":"1","author":"Song","year":"2025","journal-title":"Medicine Bulletin"},{"key":"2026090205001845000_14.6.e013562.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100888"},{"key":"2026090205001845000_14.6.e013562.17","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aab2610","article-title":"Glutamine-dependent \u03b1-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation","volume":"8","author":"Klysz","year":"2015","journal-title":"Sci Signal"},{"key":"2026090205001845000_14.6.e013562.18","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140100","article-title":"Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer","volume":"131","author":"Edwards","year":"2021","journal-title":"J Clin Invest"},{"key":"2026090205001845000_14.6.e013562.19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903586"},{"key":"2026090205001845000_14.6.e013562.20","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3439"},{"key":"2026090205001845000_14.6.e013562.21","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.240530412"},{"key":"2026090205001845000_14.6.e013562.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.02.004"},{"key":"2026090205001845000_14.6.e013562.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0379-5"},{"key":"2026090205001845000_14.6.e013562.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2020.10.015"},{"key":"2026090205001845000_14.6.e013562.25","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7692","article-title":"PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nat Commun"},{"key":"2026090205001845000_14.6.e013562.26","doi-asserted-by":"crossref","first-page":"116078","DOI":"10.1016\/j.biopha.2023.116078","article-title":"Delta-tocotrienol disrupts PD-L1 glycosylation and reverses PD-L1-mediated immune suppression","volume":"170","author":"Sun","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"2026090205001845000_14.6.e013562.27","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.096040"},{"key":"2026090205001845000_14.6.e013562.28","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.celrep.2017.10.082","article-title":"Slc3a2 Mediates Branched-Chain Amino-Acid-Dependent Maintenance of Regulatory T Cells","volume":"21","author":"Ikeda","year":"2017","journal-title":"Cell Rep"},{"key":"2026090205001845000_14.6.e013562.29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.apsb.2019.12.006","article-title":"Solute carrier transporters: the metabolic gatekeepers of immune cells","volume":"10","author":"Song","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"2026090205001845000_14.6.e013562.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2015.12.017"},{"key":"2026090205001845000_14.6.e013562.31","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adq0558","article-title":"Structural basis for the substrate recognition and transport mechanism of the human y+LAT1-4F2hc transporter complex","volume":"11","author":"Dai","year":"2025","journal-title":"Sci Adv"},{"key":"2026090205001845000_14.6.e013562.32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.624324","article-title":"Targeting SLC1A5 and SLC3A2\/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment","volume":"12","author":"Nachef","year":"2021","journal-title":"Front Immunol"},{"key":"2026090205001845000_14.6.e013562.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2020.460914"},{"key":"2026090205001845000_14.6.e013562.34","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01923-9"},{"key":"2026090205001845000_14.6.e013562.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01918-6"},{"key":"2026090205001845000_14.6.e013562.36","doi-asserted-by":"crossref","first-page":"104845","DOI":"10.1016\/j.cellimm.2024.104845","article-title":"CD147 regulates the formation and function of immune synapses","volume":"401\u2013402","author":"Xu","year":"2024","journal-title":"Cell Immunol"},{"key":"2026090205001845000_14.6.e013562.37","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M400207-MCP200"},{"key":"2026090205001845000_14.6.e013562.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2014.07.005"},{"key":"2026090205001845000_14.6.e013562.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.12.039"},{"key":"2026090205001845000_14.6.e013562.40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI30103"},{"key":"2026090205001845000_14.6.e013562.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215996"},{"key":"2026090205001845000_14.6.e013562.42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.938470"},{"key":"2026090205001845000_14.6.e013562.43","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70340","article-title":"VSIG4 Promotes Tumour\u2010Associated Macrophage M2 Polarization and Immune Escape in Colorectal Cancer via Fatty Acid Oxidation Pathway","volume":"15","author":"Liu","year":"2025","journal-title":"Clin Transl Med"},{"key":"2026090205001845000_14.6.e013562.44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01327-4"},{"key":"2026090205001845000_14.6.e013562.45","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-025-03303-z","article-title":"VSIG4+ tumor-associated macrophages mediate neutrophil infiltration and impair antigen-specific immunity in aggressive cancers through epigenetic regulation of SPP1","volume":"44","author":"Pan","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"2026090205001845000_14.6.e013562.46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1157861"},{"key":"2026090205001845000_14.6.e013562.47","doi-asserted-by":"crossref","DOI":"10.1007\/s12672-025-02411-8","article-title":"The immunosuppressive role of VSIG4 in colorectal cancer and its interaction with the tumor microenvironment","volume":"16","author":"Zhang","year":"2025","journal-title":"Discov Oncol"},{"key":"2026090205001845000_14.6.e013562.48","doi-asserted-by":"publisher","DOI":"10.1172\/JCI25673"},{"key":"2026090205001845000_14.6.e013562.49","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1016\/j.devcel.2025.04.011","article-title":"Targeting VSIG4+ tissue-resident macrophages enhances T cell cytotoxicity and immunotherapy efficacy in cancer","volume":"60","author":"Ma","year":"2025","journal-title":"Dev Cell"},{"key":"2026090205001845000_14.6.e013562.50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25116160","article-title":"Antibodies Targeting Human or Mouse VSIG4 Repolarize Tumor-Associated Macrophages Providing the Potential of Potent and Specific Clinical Anti-Tumor Response Induced across Multiple Cancer Types","volume":"25","author":"Sazinsky","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026090205001845000_14.6.e013562.51","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbrc.2022.08.055","article-title":"VSIG4-expressing tumor-associated macrophages impair anti-tumor immunity","volume":"628","author":"Jung","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"2026090205001845000_14.6.e013562.52","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1007\/s00262-023-03438-y","article-title":"Identification of a novel immune checkpoint molecule V-set immunoglobulin domain-containing 4 that leads to impaired immunity infiltration in pancreatic ductal adenocarcinoma","volume":"72","author":"Jiang","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"2026090205001845000_14.6.e013562.53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1567035","article-title":"VSIG4 as a tumor-associated macrophage marker predicting adverse prognosis in diffuse large B-cell lymphoma","volume":"16","author":"Ma","year":"2025","journal-title":"Front Immunol"},{"key":"2026090205001845000_14.6.e013562.54","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.devcel.2025.08.006","article-title":"Dual threat: VSIG4+ macrophages use IL-11 and VSIG4 to silence T cells","volume":"60","author":"Khantakova","year":"2025","journal-title":"Dev Cell"},{"key":"2026090205001845000_14.6.e013562.55","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-24-1712"},{"key":"2026090205001845000_14.6.e013562.56","first-page":"374","article-title":"Inflammasomes make the case for littermate-controlled experimental design in studying host-microbiota interactions","volume":"9","author":"Mamantopoulos","year":"2018","journal-title":"Gut Microbes"},{"key":"2026090205001845000_14.6.e013562.57","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1007\/s11427-024-2602-7","article-title":"Inhibition of the RXRA-PPAR\u03b1-FABP4 signaling pathway alleviates vascular cellular aging by an SGLT2 inhibitor in an atherosclerotic mice model","volume":"67","author":"Zhang","year":"2024","journal-title":"Sci China Life Sci"},{"key":"2026090205001845000_14.6.e013562.58","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/s43018-025-00958-7","article-title":"PILR\u03b1 on tumor cells interacts with the T cell surface protein CD99 to suppress antitumor immunity","volume":"6","author":"Xia","year":"2025","journal-title":"Nat Cancer"},{"key":"2026090205001845000_14.6.e013562.59","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41423-025-01260-3","article-title":"GLP1 alleviates oleic acid-propelled lipocalin-2 generation by tumor-infiltrating CD8+\u2009T cells to reduce polymorphonuclear MDSC recruitment and enhances viral immunotherapy in pancreatic cancer","volume":"22","author":"Wu","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"2026090205001845000_14.6.e013562.60","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s11427-024-2811-x","article-title":"Glutaminolysis and \u03b1-ketoglutarate-stimulated KCa3.1 expression contribute to \u03b2-adrenoceptor activation-induced myocardial fibrosis in mice","volume":"68","author":"Bai","year":"2025","journal-title":"Sci China Life Sci"},{"key":"2026090205001845000_14.6.e013562.61","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2026.102691","article-title":"HE4 drives PD-L1 expression in myeloid cells via IFN-\u03b3R-JAK-STAT3 signaling to promote tumor immune evasion","volume":"7","author":"Zeng","year":"2026","journal-title":"Cell Rep Med"},{"key":"2026090205001845000_14.6.e013562.62","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24482"},{"key":"2026090205001845000_14.6.e013562.63","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21871"},{"key":"2026090205001845000_14.6.e013562.64","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1038\/s41467-024-47948-4","article-title":"The complete assembly of human LAT1-4F2hc complex provides insights into its regulation, function and localisation","volume":"15","author":"Wu","year":"2024","journal-title":"Nat Commun"},{"key":"2026090205001845000_14.6.e013562.65","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700039"},{"key":"2026090205001845000_14.6.e013562.66","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63649-8"},{"key":"2026090205001845000_14.6.e013562.67","doi-asserted-by":"crossref","first-page":"3946320251346823","DOI":"10.1177\/03946320251346823","article-title":"High expression of CCL3\/CCL4\/CCL5\/CCR5 promotes exhausted CD8+ T cells terminal differentiation and is associated with poor prognosis in pediatric B-ALL patients","volume":"39","author":"Zheng","year":"2025","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2026090205001845000_14.6.e013562.68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.05.004"},{"key":"2026090205001845000_14.6.e013562.69","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210108","article-title":"Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN\u2013driven CCL5 and CXCL10","volume":"218","author":"Mowat","year":"2021","journal-title":"J Exp Med"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2025-013562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:00:27Z","timestamp":1788350427000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2025-013562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":69,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,8]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/jitc-2025-013562"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2025-013562","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}